Each agent runs one intelligence track. Its dossier below shows what it reads, how it decides, and what you receive.
Every strategic and operational move in your market: launches, M&A, partnerships, financing, entries and exits, pricing and positioning, plus the regulatory shifts that move the field. It watches your named competitor set and, crucially, the players outside it who are making moves big enough to matter.
Nothing is passed on as raw news. Each move is verified against a primary or trusted source, tiered by reliability, and graded on one question: should it change your roadmap, positioning, or M&A thinking in the next 12–24 months? Where a company is both a customer and a competitor, that tension is flagged, not buried.
A company outside your tracked set: a roll-up buying its way into adjacent territory. Confirmed via company release and trade press.
What your customers and their customers need, struggle with, and increasingly expect (end users, channel partners, and professional buyers alike), plus what's changing among your accounts: leadership and ownership shifts, expansion signals, distress warnings, etc. The moments that can open a conversation, or quietly put an account at risk.
Every observation is sorted through five lenses (need, pain, constraint, mindset, expectation) and kept only when it's attributable to a segment and actionable for a team. A trend with no customer behind it is noise; what survives is something product or marketing can act on this quarter.
Not a complaint about your product: a shift one step down the chain that changes what your buyers will require from you next.
Emerging technologies and business models, startups and corporate spinouts, patent filings and research publications, worldwide, wherever relevance to your portfolio can be established. Coverage deliberately reaches the small and early-stage: the individual inventors and academic labs that standard monitoring passes over.
Each development is classified by type and by maturity (concept, lab, patent, pilot, or product), then mapped against your own products as a direct overlap, an adjacency, or a disruptor to watch. So a promising demo is never mistaken for an imminent threat, and a real one is never missed.
Filed 14 months ago by a name you'd never track, now at commercial pilot in an adjacent market. Direct overlap with your line.
Start with a pilot at half price, or bring us the question you want answered.
